ID: ALA2368683

Max Phase: Preclinical

Molecular Formula: C32H45N3O17P2

Molecular Weight: 805.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@@H](CNCCCCCCOCc4ccc5ccccc5c4)[C@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1

Standard InChI:  InChI=1S/C32H45N3O17P2/c36-24-11-13-35(32(42)34-24)30-28(40)26(38)23(49-30)18-48-53(43,44)52-54(45,46)51-31-29(41)27(39)25(37)22(50-31)16-33-12-5-1-2-6-14-47-17-19-9-10-20-7-3-4-8-21(20)15-19/h3-4,7-11,13,15,22-23,25-31,33,37-41H,1-2,5-6,12,14,16-18H2,(H,43,44)(H,45,46)(H,34,36,42)/t22-,23+,25-,26+,27-,28+,29-,30+,31+/m0/s1

Standard InChI Key:  QWTPJEFEXQBUIZ-OXAWKINHSA-N

Associated Targets(Human)

Beta-1,4-galactosyltransferase 1 37 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 805.66Molecular Weight (Monoisotopic): 805.2224AlogP: -0.27#Rotatable Bonds: 19
Polar Surface Area: 298.02Molecular Species: ZWITTERIONHBA: 17HBD: 9
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.73CX Basic pKa: 9.17CX LogP: -1.96CX LogD: -4.13
Aromatic Rings: 3Heavy Atoms: 54QED Weighted: 0.06Np Likeness Score: 0.72

References

1. Takaya K, Nagahori N, Kurogochi M, Furuike T, Miura N, Monde K, Lee YC, Nishimura S..  (2005)  Rational design, synthesis, and characterization of novel inhibitors for human beta1,4-galactosyltransferase.,  48  (19): [PMID:16162007] [10.1021/jm0504297]

Source